Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
To date, health organizations and countries around the world are struggling to completely control the spread of the coronavirus disease 2019 (COVID-19). Scientists and researchers are developing tests for the rapid detection of individuals who may carry the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while striving to find a suitable vaccine to immunize healthy individuals. As there are clinically reported cases of asymptomatic carriers of SARS-CoV-2, fast and accurate diagnosis plays an important role in the control and further prevention of this disease. Herein, we present recent technologies and techniques that have been implemented for the diagnosis of COVID-19. We summarize the methods created by different research institutes as well as the commercial devices and kits developed by companies for the detection of SARS-CoV-2. The description of the existing methods is followed by highlighting their advantages and challenges. Finally, we propose some promising techniques that could potentially be applied to the detection of SARS-CoV-2, and tracing the asymptomatic carriers of COVID-19 rapidly and accurately in the early stages of infection, based on reviewing the research studies on the detection of similar infectious viruses, especially severe acute respiratory syndrome (SARS) coronavirus, and Middle East respiratory syndrome (MERS) coronavirus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Loop-mediated isothermal amplification of DNA
Notomi, T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.e63 · Cited by 8,805
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030 · cited 1×
“Recent studies found that feces and urine samples of infected individuals may carry live SARS-CoV-2 that can later enter the wastewater system (Holshue et al., 2020).”
BackgroundThe proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510 · cited 1×
“SARS emerged as a pandemic in 2002 in Guangdong, China, leading to more than 8000 confirmed cases and 774 deaths as it spread throughout the world with an approximately 10% mortality rate (De Wit et al., 2016; WHO, 2015).”
BackgroundA crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445 · cited 1×
“Several studies (e.g., Imai et al., 2005; Kuba et al., 2005) have highlighted angiotensin-converting enzyme 2 (ACE2) as the functional receptor of SARS-CoV in vitro and in vivo.”
BackgroundCell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109 · cited 1×
“…SARSCoV-2 are from lineage B of the Betacoronavirus genus, while MERS-CoV belongs to the lineage C of the Betacoronavirus genus (Chan et al., 2020a; Letko et al., 2020; Mohd et al., 2016), which explains 79.6% of the sequence identity and the multiple similarities of SARS-CoV and SARS-CoV-2…”
BackgroundInfluentialCT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
Chung, M., Bernheim, A., Mei, X., Zhang, N., Huang, M., Zeng, X., Cui, J., Xu, W., Yang, Y., Fayad, Z. A., et al. (2020) · Radiology · doi:10.1148/radiol.2020200230 · Cited by 2,751 · cited 2×
“The false-negative results of initial RT-PCR were in line with the results from other reported studies (Chung et al., 2020; Xie et al., 2020).”
BackgroundResultStructure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740 · cited 1×
“As the spike (S) protein structure and receptor binding domain of SARS-CoV-2 is very similar to that of SARS-CoV (Andersen et al., 2020; Li, 2016; Lu et al., 2020), many hypotheses have arisen indicating that they probably use the same host cell receptor.”
MethodAngiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122 · cited 1×
“Supporting the aforementioned hypothesis, a recent study (Monteil et al., 2020) indicated that both SARS-CoV and SARS-CoV-2 use the same ACE2 receptor to infect humans.”
ResultXie, X., Zhong, Z., Zhao, W., Zheng, C., Wang, F., & Liu, J. (2020) · Radiology · doi:10.1148/radiol.2020200343 · Cited by 1,960 · cited 3×
“This was found to be the case even for asymptomatic individuals or patients with initial negative RT-PCR but clinical symptoms, thus showing that CT scans have higher sensitivity compared with RT-PCR (Ai et al., 2020; Fang et al., 2020; Xie et al., 2020).”
BackgroundResultViral load of SARS-CoV-2 in clinical samples.
Pan, Y., Zhang, D., Yang, P., Poon, L. L. M., & Wang, Q. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30113-4 · Cited by 1,562 · cited 1×
“Another variable of the final results of the detection test kits is the time that the samples have been taken, as the viral load varies on different days after the infection (Pan et al., 2020; Yang et al., 2020).”
BackgroundYang, Y., Yang, M., Shen, C., Wang, F., Yuan, J., Li, J., Zhang, M., Wang, Z., Xing, L., Wei, J., et al. (2020) · doi:10.1101/2020.02.11.20021493 · Cited by 836
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir
Mohd, H. A., Al-Tawfiq, J. A., & Memish, Z. A. (2016) · Virology Journal · doi:10.1186/s12985-016-0544-0 · Cited by 316 · cited 1×
“…are from lineage B of the Betacoronavirus genus, while MERS-CoV belongs to the lineage C of the Betacoronavirus genus (Chan et al., 2020a; Letko et al., 2020; Mohd et al., 2016), which explains 79.6% of the sequence identity and the multiple similarities of SARS-CoV and SARS-CoV-2 (Kumar, 2020).”
BackgroundInfluential
Cited by
Point-of-care COVID-19 diagnostics powered by lateral flow assay
Zhou, Y., Wu, Y., Ding, L., Huang, X., & Xiong, Y. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116452 · Cited by 180
Metadata
- Authors
- Taleghani, N., & Taghipour, F.
- Venue
- Biosensors and Bioelectronics
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 174
- Pages
- 112830
- ISSN
- 0956-5663 (ISSN-L)
- OpenAlex
- W3107122234
- Cited by
- 201
- References
- 17
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.